Optimum bolus wizard settings in insulin pumps in children with Type 1 diabetes

A J B Andersen1, A Ostenfeld2, C B Pipper3

  • 1Faculty of Health and Medical Sciences, University of Copenhagen, Herlev, Denmark. amandabjerre@gmail.com.

Insights

Insulin pump settings for children require individualization. Standardized factors are not constant, necessitating age- and dose-dependent adjustments for optimal diabetes management in pediatric patients.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Technology

Background:

  • Optimizing insulin pump therapy in children with type 1 diabetes is crucial for glycemic control.
  • The Bolus Wizard feature aims to simplify insulin dose calculations but requires accurate input factors.

Purpose of the Study:

  • To evaluate current insulin pump settings in a well-regulated pediatric population using the Bolus Wizard.
  • To identify factors influencing insulin-to-carbohydrate and insulin sensitivity factors in children on insulin pump therapy.

Main Methods:

  • Retrospective analysis of data from 124 children with optimal HbA1c levels on insulin pump therapy.
  • Utilized Bolus Wizard settings to derive insulin-to-carbohydrate and insulin sensitivity factors.
  • Employed multiple regression analysis to identify variables associated with these calculation factors.

Main Results:

  • Insulin-to-carbohydrate factor increased with age, ranging from 276 to 424.
  • Insulin sensitivity factor was highest in the 6 to <12 years age group (125).
  • Age, carbohydrate intake, bolus frequency, and insulin dosage per kg were significantly associated with both factors; treatment duration and basal/bolus ratio also showed associations.

Conclusions:

  • Optimal insulin pump settings at initiation are influenced by individual insulin needs and pump usage patterns.
  • Standardized calculation factors are inadequate for children, highlighting the need for personalized settings.
  • Development of specific age- and insulin dose-dependent calculation factors is recommended for improved pediatric insulin pump management.
Abstract

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
919
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
1.1K
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
1.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
733
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
474